Geneesmiddelenbeleid

This procedure involves a written consultation report concerning pharmaceutical policies. It focuses on how the Netherlands coordinates its approach to medicine regulation, availability, and healthcare costs within the broader European context. This affects healthcare providers, pharmaceutical companies, and patients by influencing how medicines are approved and priced in the Dutch market.